The roles, molecular interactions, and therapeutic value of CDK16 in human cancers

Biomed Pharmacother. 2023 Aug:164:114929. doi: 10.1016/j.biopha.2023.114929. Epub 2023 May 24.

Abstract

Cyclin-dependent kinase 16 (CDK16) is an orphan "cyclin-dependent kinase" (CDK) involved in the cell cycle, vesicle trafficking, spindle orientation, skeletal myogenesis, neurite outgrowth, secretory cargo transport, spermatogenesis, glucose transportation, cell apoptosis, cell growth and proliferation, metastasis, and autophagy. Human CDK16 is located on chromosome Xp11.3 and is related to X-linked congenital diseases. CDK16 is commonly expressed in mammalian tissues and may act as an oncoprotein. It is a PCTAIRE kinase in which Cyclin Y or its homologue, Cyclin Y-like 1, regulates activity by binding to the N- and C- terminal regions of CDK16. CDK16 plays a vital role in various cancers, including lung cancer, prostate cancer, breast cancer, malignant melanoma, and hepatocellular carcinoma. CDK16 is a promising biomarker for cancer diagnosis and prognosis. In this review, we summarized and discussed the roles and mechanisms of CDK16 in human cancers.

Keywords: CDK16; Cancer; Cell cycle; PCTAIRE1; PCTK1.

Publication types

  • Review

MeSH terms

  • Animals
  • Cell Cycle
  • Cell Division
  • Cyclins / metabolism
  • Humans
  • Lung Neoplasms*
  • Male
  • Skin Neoplasms*

Substances

  • Cyclins
  • PCTAIRE-1 protein kinase